Presentation TCT 2018

TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results

Presenter: Thomas Gleason

September 21, 2018

REGISTER for free or LOG IN to view this content

TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results

Coronary

Presentation

TCT 2018

Up Next

Presentation TCT 2018

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Presenter: Nicolas Dumontiel

September 21, 2018

More slides +

Presentation TCT 2018

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

Presenter: Michael J. Reardon

September 21, 2018

Presentation TCT 2018

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Presenter: Matthew Summers

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.